Update on anti-tumour necrosis factor agents and other new drugs...
Inflammatory bowel diseases can be difficult to characterise and costly to treat. It affects about four million people worldwide. For decades after the first recognition of IBD the only effective treatment was surgery. In the middle of the 20th century medical therapies emerged in the form of aminosalicylates,...
Read more